“Repurposing FDA-Approved Antimalarial Drugs: Mefloquine As a Promising Multi-Targeted Therapeutic for Non-Small Cell Lung Cancer: Repurposing Antimalarials: Mefloquine for Multi-Targeted NSCLC Therapy”. Indian Journal of Chemistry (IJC), vol. 64, no. 7, July 2025, pp. 730-45, https://doi.org/10.56042/ijc.v64i7.16642.